Literature DB >> 10367038

High prevalence of low femoral bone mineral density in elderly women living in nursing homes or community-dwelling: a plausible role of increased parathyroid hormone secretion.

J Y Reginster1, R Deroisy, H Pirenne, I Frederick, W Dewe, A Albert, J Collette, S X Zheng, C Gosset.   

Abstract

The present study was designed to visit elderly women living in nursing homes and to compare their femoral neck bone mineral density (BMD) and circulating levels of parathyroid hormone (PTH) and 25-OH vitamin D (25-OHD) with those of subjects living at home, in the immediate vicinity of the nursing homes. Of 1483 women, aged 70 years and older, who were selected, 993 agreed to participate in this trial. Their femoral neck BMD (n = 993) was measured by dual-energy X-ray absorptiometry, with a specific device installed in a mobile truck. The circulating levels of 25-OHD and PTH were assessed after an overnight fast (n = 748). After stratification for age, there were no significant differences in mean femoral neck BMD values, prevalence of femoral neck osteoporosis, mean serum 25-OHD and prevalence of absolute or relative 25-OHD deficiency between the two groups. Serum levels of PTH were significantly higher in women over 80 years old living in nursing homes, compared with the community-dwelling women. After adjustment for age, a significant relation was found between femoral neck BMD and PTH levels in the whole population (p = 0.004) and in community-dwelling subjects (p = 0.039). When stratifying our population by quartiles of serum PTH values, the odds ratios for femoral neck osteoporosis were significantly increased for the top two quartiles compared with the lowest one both before (p = 0.00146) and after (p = 0.0013) adjustment for age and type of housing. From this study we conclude that femoral osteoporosis is largely underestimated in European women. Living in a nursing home is not, per se, a risk factor for decreased femoral BMD, and circulating PTH levels are a key determinant of low femoral bone density and osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367038     DOI: 10.1007/s001980050124

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  7 in total

1.  The direct and indirect costs of the chronic management of osteoporosis: a prospective follow-up of 3440 active subjects.

Authors:  V Rabenda; C Manette; R Lemmens; A-M Mariani; N Struvay; J-Y Reginster
Journal:  Osteoporos Int       Date:  2006-06-24       Impact factor: 4.507

2.  Risk factors of osteoporosis in institutionalized older Thai people.

Authors:  P Assantachai; W Angkamat; P Pongpim; C Weattayasuthum; C Komoltri
Journal:  Osteoporos Int       Date:  2006-03-17       Impact factor: 4.507

3.  Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels.

Authors:  P Pennisi; S S Signorelli; S Riccobene; G Celotta; L Di Pino; T La Malfa; C E Fiore
Journal:  Osteoporos Int       Date:  2003-12-06       Impact factor: 4.507

4.  Rapid correction of low vitamin D status in nursing home residents.

Authors:  R Przybelski; S Agrawal; D Krueger; J A Engelke; F Walbrun; N Binkley
Journal:  Osteoporos Int       Date:  2008-04-18       Impact factor: 4.507

Review 5.  The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report.

Authors:  S Boonen; R Rizzoli; P J Meunier; M Stone; G Nuki; U Syversen; M Lehtonen-Veromaa; P Lips; O Johnell; J-Y Reginster
Journal:  Osteoporos Int       Date:  2004-07       Impact factor: 4.507

6.  Prevalence of vitamin D insufficiency and low bone mineral density in elderly Thai nursing home residents.

Authors:  Anuk Kruavit; La-or Chailurkit; Ammarin Thakkinstian; Chutintorn Sriphrapradang; Rajata Rajatanavin
Journal:  BMC Geriatr       Date:  2012-09-02       Impact factor: 3.921

7.  Vitamin D inadequacy in Belgian postmenopausal osteoporotic women.

Authors:  Audrey Neuprez; Olivier Bruyère; Julien Collette; Jean-Yves Reginster
Journal:  BMC Public Health       Date:  2007-04-26       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.